Metoclopramide Hydrochloride Patent Expiration
Metoclopramide Hydrochloride was first introduced by Ani Pharmaceuticals Inc
Metoclopramide Hydrochloride Patents
Given below is the list of patents protecting Metoclopramide Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gimoti | US8334281 | Nasal formulations of metoclopramide | May 16, 2030 | Evoke Pharma Inc |
| Gimoti | US11020361 | Nasal formulations of metoclopramide | Dec 22, 2029 | Evoke Pharma Inc |
| Gimoti | US11628150 | Nasal formulations of metoclopramide | Dec 22, 2029 | Evoke Pharma Inc |
| Gimoti | US11813231 | Nasal formulations of metoclopramide | Dec 22, 2029 | Evoke Pharma Inc |
| Gimoti | US12194008 | Nasal formulations of metoclopramide | Dec 22, 2029 | Evoke Pharma Inc |
| Gimoti | US12194009 | Nasal formulations of metoclopramide | Dec 22, 2029 | Evoke Pharma Inc |
| Gimoti | US6770262 | Nasal administration of agents for the treatment of gastroparesis |
Mar 29, 2021
(Expired) | Evoke Pharma Inc |
| Reglan Odt | US6024981 | Rapidly dissolving robust dosage form |
Apr 09, 2018
(Expired) | Meda Pharms |
| Reglan Odt | US6221392 | Rapidly dissolving robust dosage form |
Apr 09, 2018
(Expired) | Meda Pharms |
| Metozolv Odt | US6413549 | Fast-Dispersing solid oral dosage form containing coarse particles |
Jul 11, 2017
(Expired) | Salix Pharms |
Metoclopramide Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List